Thursday, January 03, 2019 3:40:43 PM
$0- it would have been taken private by an Israeli company like STEM.
Xena — Agree with what I think is the thrust of your statement. Woodford would have sold NWBO (for a premium of maybe 25 to 75%) and the treatment would have been effectively buried, at least in the US. Just my guess as to the most likely outcome based on past experience with cell-based companies like Medistem and TiGenix.
Regarding STEM - do you mean Stemline Therapeutics? They’re US-based as far as I know —I’m a shareholder, and if they’re based in Israel I should dig a little deeper
Recent NWBO News
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
